Management EfficiencyThe company has return on total asset (ROA) of (15.42) % which means that it has lost $15.42 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (47.45) % meaning that it generated substantial loss on money invested by shareholders.
Entity SummaryGenfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver worldwide. Genfit SA was founded in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in USA and traded on OTC Market. It employs 125 people.Genfit SA (GNFTF) is traded on OTC Market in USA. It is located in Parc Eurasant? and employs 125 people.
Genfit SA Leadership Team
Stock Performance Indicators